Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
16
INTS Quote, Financials, Valuation and Earnings
Last price:
$0.33
Seasonality move
:
-27.87%
Day range:
$0.31 - $0.34
52-week range:
$0.26 - $5.01
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
17.92x
Volume:
2.5M
Avg. volume:
3.2M
1-year change:
-93.39%
Market cap:
$6M
Revenue:
--
EPS (TTM):
-$1.05
Earnings Data
Next earnings date for INTS
Aug 08
2025
Most recent earnings per share
-$0.22
Missed by $0.09
(May 13/2025)
Consensus Estimate
-$0.13
(May 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
INTS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.16 | -- |
| 08/08/2025 | Q2 | -- | -- | -- | -$0.18 | -- |
| 05/13/2025 | Q1 | -- | -- | -$0.22 | -$0.13 | -$0.09 |
| 03/13/2025 | Q4 | -- | -- | -$0.22 | -$0.23 | $0.01 |
| 11/13/2024 | Q3 | -- | -- | -$0.25 | -- | -- |
| 08/08/2024 | Q2 | -- | -- | -$0.36 | -- | -- |
| 05/09/2024 | Q1 | -- | -- | -$0.34 | -- | -- |
| 03/14/2024 | Q4 | -- | -- | -$0.23 | -- | -- |
| 11/13/2023 | Q3 | -- | -- | -$0.17 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$1.43 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.10 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.43 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.50 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.55 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.18 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.68 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.12 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.54 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.42 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.08 | -- | -- |
Intensity Therapeutics Earnings Questions
-
How Much did Intensity Therapeutics Generate in Revenue Last Quarter?
Intensity Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Intensity Therapeutics Beat Earnings Last Quarter?
Intensity Therapeutics announced earnings per share of -$0.22 which represents a miss of analyst forecast a -$0.13 per share.
-
Is Intensity Therapeutics Profitable?
Intensity Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Intensity Therapeutics EPS Next Year?
Intensity Therapeutics's earnings are forecast to decrease from -$1.17 per share to -$1.18 per share next year representing a decrease of -40.17%.
-
When is Intensity Therapeutics's Earnings Date?
Intensity Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
